Atlas Trials

A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid Arthritis

Clinical trial NCT00713544 · COMPLETED

Trial details

NCT number
NCT00713544
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Rheumatoid Arthritis
Start date
2008-07-01
Primary completion
2009-04-01
Enrollment
373

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.